Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-049795)

Filing Details

Accession Number:: 0001209191-20-049795
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-08 20:00:49
Reporting Period:: 2020-09-08

Accepted Time:: 2020-09-08 20:00:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1566044	Vyne Therapeutics Inc.	VYNE	Pharmaceutical Preparations (2834)	453757789

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1727794	David Domzalski	520 U.s. Highway 22, Suite 204 Bridgewater NJ 08807	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-08	75,000	$1.38	1,315,966	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.48 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.